紫杉醇联合阿霉素治疗晚期乳腺癌临床观察与护理  

Clinical observation and nursing of Paclitaxel and adriamycin in treatment of advanced breast cancer

作　　者：邓丽娟[1] 

机构地区：[1]四川省凉山彝族自治州第一人民医院长安分院肿瘤科,四川省西昌市615000

出　　处：《临床合理用药杂志》2011年第24期9-10,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的观察紫杉醇联合阿霉素治疗晚期乳腺癌的效果,并探讨护理措施。方法 68例晚期乳腺癌患者随机分为观察组和对照组各34例,观察组采用紫杉醇联合阿霉素治疗,对照组采用阿霉素联合环磷酰胺治疗,观察2组疗效。结果观察组总有效率为50.0%,高于对照组的23.5%,差异有统计学意义(P<0.05)。结论紫杉醇联合阿霉素治疗晚期乳腺癌,结合有效护理,效果明显。Objective To observe the effect of paclitaxel and adriamycin in treatment of advanced breast cancer and explore nursing interventions.Methods 68 cases of advanced breast cancer were randomly divided into observation group and control group（34 in each） according to their wishes,the observed group was treated with paclitaxel and adriamycin treatment,while the control group with doxorubicin and cyclophosphamide therapy,and the effect was observed.Results The effect rate in observation group was 50.0%,was higher than 23.5% in the control group,and the difference was statistically significant（P0.05）.Conclusion Paclitaxel and doxorubicin combination treatment of advanced breast cancer reasonable care is significant.

关 键 词：紫杉醇 阿霉素 乳腺癌 晚期 护理 

分 类 号：R473.73[医药卫生—护理学]